Millions of people take blood pressure medication daily, often for life, but new research suggests a hidden hormonal cause could be behind many cases. A cardiologist has warned that primary aldosteronism, a condition estimated to account for around five to ten per cent of high blood pressure cases, is frequently overlooked. The findings raise the possibility that treating the underlying cause, rather than simply controlling symptoms, could deliver lasting results.
Study shows lasting improvements after short treatment
A study led by Queen Mary University of London, published in the New England Journal of Medicine on November 7, suggests a new class of medication could potentially reverse the underlying hormonal problem. Researchers followed 14 patients with primary aldosteronism who received six to 12 months of treatment with aldosterone synthase inhibitors, which block production of the hormone. Improvements in hormone levels and blood pressure were sustained for up to two years after treatment stopped.
The main marker of excess aldosterone remained 99 per cent lower than before treatment, while blood pressure fell by an average of 25 points. Almost a quarter of participants achieved normal blood pressure without other medication.
Cardiologist highlights importance of finding the cause
Dr Francesco Lo Monaco, cardiologist and founder of The National Heart Clinic, says the findings could represent an important shift in how doctors approach certain cases of hypertension. He said: “High blood pressure is often treated as a condition that needs to be managed indefinitely, but we should always be asking why someone’s blood pressure is elevated in the first place.”
He added: “In some patients, there may be an identifiable underlying cause that is driving the problem. If we can treat that cause rather than simply control the blood pressure, the long-term benefits could be significant. What makes this research particularly interesting is the possibility that a relatively short course of medication could produce lasting changes, rather than simply keeping blood pressure down while someone continues taking tablets.”
Warning signs and the need for further investigation
Primary aldosteronism can be difficult to identify because its symptoms are often absent or easily mistaken for other health problems. However, people whose blood pressure remains high despite taking several medications, or those with unusually low potassium levels, may warrant further investigation.
Dr Lo Monaco said: “One of the biggest mistakes is assuming that high blood pressure is simply an inevitable consequence of getting older or lifestyle. If someone’s readings remain elevated despite treatment, it is important to investigate whether something else could be contributing. Identifying an underlying hormonal problem could change the way that person’s condition is managed.”
He also advised: “People should not assume that their existing medication isn’t working or stop taking it themselves. They should speak to their doctor about whether further investigation is appropriate.”
Research still preliminary
The researchers have stressed that the findings are preliminary. The study involved only 14 patients, and larger clinical trials are now needed to establish whether the treatment can reliably produce lasting remission. Dr Lo Monaco added: “We need to be careful not to suggest that this is a cure for high blood pressure generally. It relates to a specific hormonal condition, and much more research is needed.”
He concluded: “But the bigger message is important: sometimes the key to better heart health is not simply adding another medication, but understanding what is driving the problem in the first place.”